Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm PR Newswire (Press Release) 17:01 Tue, 28 Apr
Slno Deadline: Rosen Law Firm Urges Soleno Therapeutics, Inc. (Nasdaq: Slno) Stockholders to Contact the Firm for Information About Their Rights Business Wire (Press Release) 16:43 Mon, 27 Apr
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Hiding Post-Launch Safety Crisis: Levi & Korsinsky PR Newswire (Press Release) 14:06 Wed, 22 Apr
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm PR Newswire (Press Release) 14:01 Tue, 21 Apr
Robbins LLP Encourages Slno Stockholders to Contact the Firm for Information About the Class Action Against Soleno Therapeutics, Inc. Business Wire (Press Release) 20:34 Mon, 20 Apr
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO PR Newswire (Press Release) 03:08 Sat, 18 Apr
This Soleno Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Benzinga 12:51 Wed, 08 Apr Article paywall
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement The Motley Fool 22:29 Mon, 06 Apr
Market movers: Virgin Galactic, Soleno Therapeutics, Medicus Pharma... Proactive Investors (US) 19:30 Mon, 06 Apr
Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.'s Transaction with Neurocrine is Fair to Public Shareholders PR Newswire (Press Release) 15:57 Mon, 06 Apr
Soleno Therapeutics, Playtika Holding And Other Big Stocks Moving Higher On Monday Benzinga 15:37 Mon, 06 Apr Article paywall
Neurocrine Biosciences to acquire Soleno Therapeutics in $2.9B deal Proactive Investors (US) 14:56 Mon, 06 Apr
Slno Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders Business Wire (Press Release) 14:43 Mon, 06 Apr
Neurocrine To Acquire Soleno Therapeutics; Slno Shares Surge 33% Pre-Market RTT News 13:09 Mon, 06 Apr
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio PR Newswire (Press Release) 12:06 Mon, 06 Apr
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 PR Newswire (Press Release) 14:14 Fri, 03 Apr